Pharma IQ Logistics Report
Why digital transformation is essential in the pharma supply chain
Published:
The Covid-19 pandemic exposed the weaknesses in global pharmaceutical supply chains when it caused governments to shut their borders and manufacturing plants to close. Existing problems such as shortages of generic drugs and logistical and regulatory challenges hindered the ability of many organizations to quickly recover from disruptions.
This report covers the following:
How the pandemic impacted supply chains globally, exacerbating existing difficulties
The value of real-time monitoring tools
How digital transformation leads to more resilient supply chains
